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ABSTRACT
OBJECTIVE
To quantify the association between major surgery 
and the age related cognitive trajectory.
DESIGN
Prospective longitudinal cohort study.
SETTING
United Kingdom.
PARTICIPANTS
7532 adults with as many as five cognitive 
assessments between 1997 and 2016 in the 
Whitehall II study, with linkage to hospital episode 
statistics. Exposures of interest included any major 
hospital admission, defined as requiring more than 
one overnight stay during follow-up.
MAIN OUTCOMES MEASURES
The primary outcome was the global cognitive 
score established from a battery of cognitive tests 
encompassing reasoning, memory, and phonemic 
and semantic fluency. Bayesian linear mixed effects 
models were used to calculate the change in the age 
related cognitive trajectory after hospital admission. 
The odds of substantial cognitive decline induced 
by surgery defined as more than 1.96 standard 
deviations from a predicted trajectory (based on 
the first three cognitive waves of data) was also 
calculated.
RESULTS
After accounting for the age related cognitive 
trajectory, major surgery was associated with a small 
additional cognitive decline, equivalent on average to 
less than five months of aging (95% credible interval 
0.01 to 0.73 years). In comparison, admissions for 
medical conditions and stroke were associated with 
1.4 (1.0 to 1.8) and 13 (9.6 to 16) years of aging, 
respectively. Substantial cognitive decline occurred 
in 2.5% of participants with no admissions, 5.5% 
of surgical admissions, and 12.7% of medical 
admissions. Compared with participants with no 
major hospital admissions, those with surgical or 
medical events were more likely to have substantial 
decline from their predicted trajectory (surgical 
admissions odds ratio 2.3, 95% credible interval 1.4 
to 3.9; medical admissions 6.2, 3.4 to 11.0).
CONCLUSIONS
Major surgery is associated with a small, long term 
change in the average cognitive trajectory that is 
less profound than for major medical admissions. 
The odds of substantial cognitive decline after 
surgery was about doubled, though lower than for 
medical admissions. During informed consent, this 
information should be weighed against the potential 
health benefits of surgery.
Introduction
Cognitive decline and dementia are major healthcare 
concerns at older ages owing to considerable personal 
and societal burdens. Cognitive decline starts before 
conventional definitions of old age1 (often 65 years) 
and accelerates with aging and accumulation of 
comorbidities.2-4 Certain health events, such as 
stroke, can lead to profound changes in the cognitive 
trajectory such that there is a permanent “step change” 
in cognitive function.5 For 60 years a major concern has 
been that surgery might also drive long term changes 
in cognition6; our recent survey suggested that 65% of 
the public are concerned about postoperative cognitive 
deficits,7 perhaps leading to refusal of surgery that 
might otherwise have health benefits.8 9 Yet studies 
investigating associations between surgery and long 
term cognitive outcomes have produced inconsistent 
results, with reports of cognitive harm,10  11 no 
effect,12-14 and cognitive improvement.15 Despite 
inconclusive evidence, considerable concern remains 
about the potential for surgery to induce cognitive 
impairment.7  16 Longer life expectancy implies an 
increasing number of surgical operations in older 
adults, hence a better understanding of the extent 
of any change in cognition after surgery is urgently 
required.
Research on postoperative cognitive decline has 
several limitations. First, most studies have a single 
preoperative assessment of cognitive function8 17 and 
not a person specific cognitive trajectory before the 
surgical event. Consequently, any decline detected 
postoperatively could be falsely attributed to the 
surgery rather than to the individual’s preoperative 
cognitive trajectory. Second, studies also typically fail 
to consider the impact of medical events5 18 such as 
stroke,5 which likely have a large cognitive impact and 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Concerns are that surgery might be associated with long term cognitive harm
Studies investigating these associations have yielded inconsistent results, partly 
due to methodological issues with assessment of cognition longitudinally
A major problem is the lack of attention to the cognitive trajectory, as cognitive 
decline accelerates with advancing age
WHAT THIS STUDY ADDS
Our study suggests that after consideration for the age related cognitive 
trajectory, major surgery on average is associated with a small cognitive decline 
equivalent to about five months of cognitive aging
The odds of substantial cognitive decline is approximately doubled after surgery, 
though the odds are lower than for non-surgical admissions
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cluster with major surgical events. Third, most studies 
are small, with a limited set of confounding factors. 
Fourth, studies often do not include “positive controls” 
to aid in the interpretation of any null or borderline 
finding. Finally, despite notable exceptions,13 14 19 the 
duration of cognitive follow-up is typically less than 
one year, limiting inference on the long term impact of 
surgery on cognition.
We addressed these concerns using cognitive data 
from 7532 adults, investigating whether incident major 
surgical admissions are related to long term changes 
in the cognitive trajectory, using five waves of cognitive 
assessments spanning approximately 20 years, 
with adjustment for major medical admissions. To 
facilitate interpretation of results, we translate effect 
estimates to equivalent years of cognitive aging and 
relate changes to the effect of stroke, an event with an 
established impact on cognition. Reference points such 
as these enable discussions of informed consent with 
patients, allowing them to weigh the risks of cognitive 
injury more easily. We primarily aimed to establish the 
mean population effect of major surgery on cognitive 
decline. As a secondary outcome we developed a 
binary outcome of substantial cognitive decline, 
more analogous methodologically to prior studies 
of postoperative cognitive decline10 and consistent 
with clinically important deviations from the age 
related cognitive trajectory.20 It allows some further 
correspondence to the prior literature and emphasizes 
cognitive changes that could impact quality of life.
Methods
Study design and participants
The Whitehall II study is a prospective cohort study 
comprised of employees from the British civil service 
in London based offices. A total of 10 308 people (6895 
men and 3413 women, aged 35-55 at enrollment) 
were recruited between 1985 and 1988. In 1997, 
when participants were 45-69 years old, a cognitive 
test battery was introduced to the study and the test 
repeated four times. Age span across the follow-up was 
44-86 years (median age 64); mean 3.8 assessments 
per person, maximum follow-up 19.4 years (mean 
12.9 years).
Exposures
The events (major surgical or admissions for medical 
conditions) were defined as hospital admissions 
requiring at least two overnight stays (excluding 
ambulatory or outpatient events) as identified in the 
hospital episode statistics database of National Health 
Service hospitals, which covers admissions in England, 
Scotland, and Wales. High quality data have been 
available since 1997, with audits of discharge reports 
indicating a 96% accuracy over our study period.21
Surgical admissions in hospital episode statistics 
were defined by Office of Population, Censuses, and 
Services (OPCS) codes (see appendix 1). Our primary 
definition of major surgery required a hospital 
admission of at least two nights (this being consistent 
with definitions currently used in major perioperative 
clinical trials22-24) linked to an OPCS code. Emergency 
admissions were identified by specific OPCS codes 
designated as an emergency procedure. Minor surgery 
was an OPCS coded admission that did not incur a 
minimum stay of two nights. Medical admissions were 
identified by ICD-10 codes (international classification 
of diseases, 10th revision) and similarly required a 
hospital admission of at least two nights.
To limit effects of transfers within hospitals, we 
linked any admissions within 14 days. If OPCS codes 
were identified during this time, we treated the 
entire admission as a surgical admission. This design 
was used to ensure that complications of surgical 
admissions were grouped with the operations but 
might, if anything, weight the analysis toward finding 
an exaggerated relation with surgery. We retained those 
admitted during the study period but without cognitive 
follow-up for use in adjusting baseline cognitive scores 
(such that surgical admissions thoughout the study 
period were treated the same when modeling cognitive 
scores, even if cognitive data were missing later).
We also conducted a sensitivity analysis rating 
procedures for surgical risk based on BUPA (a 
private health insurance scheme) scores as used 
in the surgical risk scale.25 Procedures were rated 
by two authors (RDS and HJM). The surgical risk 
scale includes various parameters to estimate, 
including patient comorbidities and the planned 
procedure, rated for severity on the BUPA scale. 
We have previously shown that higher BUPA rating 
of procedure severity (rated by RDS and HJM) is 
associated with higher risk of 30 day postoperative 
mortality.26 In our sensitivity analysis, the definition 
of major surgery required both a BUPA definition of a 
major procedure and a hospital admission of at least 
two nights. This analysis was designated as BUPA 
major.
Out of 43 692 entries in hospital episode statistics 
during the study period (for 7532 participants), 35 099 
remained after linkage. We compared major surgical 
events for the entire group with those for whom 
cognitive follow-up was available, organized according 
to higher risk surgical categories that have plausible 
associations with cognitive outcomes (cardiac, 
thoracic, vascular, and intracranial operations).10 11 
The proportions were similar, suggesting that cognitive 
follow-up was available for a representative cross 
section of operations in the study population.
Outcomes
The primary outcome was the global cognitive score, 
calculated from the cognitive domains tested (memory, 
executive function, and verbal fluency), as in previous 
analyses of these data.1 27 28 The cognitive test battery 
was administered in 1997-99 (age range 44-68 years), 
2002-04, 2007-09, 2012-13, and 2015-16 (age 
range 62-86 years). In 1997-99, 556 participants 
underwent retesting within three months of their 
initial assessment, with good test-retest reliability 
(range 0.6-0.9). Memory was tested using a 20 word 
free recall test where one or two syllable words were 
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presented at two second intervals and participants 
were asked to write down as many of the words they 
could recall in two minutes. Executive function was 
assessed using the Alice Heim 4-I test, which includes 
65 verbal and mathematical reasoning items with 
increasing difficulty. This test measures a participant’s 
ability to identify patterns and infer principles or rules 
over the 10 minute test. Verbal fluency was assessed 
using measures of phonemic and semantic fluency, 
with participants asked to write as many words as 
possible beginning with “s” (phonemic) or animal 
names (semantic) in one minute. The primary outcome 
of the global cognitive score was calculated by first 
standardizing the raw scores for each cognitive domain 
to z scores using mean and standard deviation from the 
first wave of cognitive data collection (1997-99). Then 
we summed the z scores across cognitive domains 
and standardized them to yield the global score. This 
approach minimizes potential measurement error in 
any individual test.
Covariates
Most covariates were drawn from the 1997-99 
assessment, though we coded covariates such as 
diabetes as occurring “ever” based on all assessments. 
These comprised of sex, ethnicity, education level, 
maximum occupational position, diabetes mellitus, 
and smoking status. Additionally, measures of married 
or cohabitating status and Framingham cardiovascular 
disease risk score29 were updated alongside the 
cognitive assessment. We also included the number 
of cognitive assessments for each participant as a 
covariate.
Statistical models
We estimated the offset in age related cognitive 
trajectory associated with cumulative major 
surgical, non-surgical, and stroke related hospital 
admissions. We report the 95% credible intervals 
on these estimates, which are close to confidence 
intervals derived using maximum likelihood or 
restricted maximum likelihood estimation. We used 
Markov chain Monte Carlo simulations to fit linear 
mixed effects models with random intercepts for 
participant and random slopes for age, accounting for 
variation between participants in baseline cognitive 
performance and in cognitive trajectory. Fixed 
effects represented the age related cognitive decline 
and the shift in cognitive performance according to 
the cumulative incidence of surgical and medical 
hospital admissions before the time of cognitive 
assessment. We separated medical admissions for 
stroke events because of the expected substantial 
cognitive impact after stroke.5 A quadratic term for 
age was included to account for an accelerated rate of 
decline with increasing age.28 Because our focus was 
on changes after surgery, we also included baseline 
adjustments for numbers of surgery, medical, and 
stroke admissions (including events that occurred 
after cognitive follow-up but during the range of years 
analyzed), and for two way interactions between 
them to ensure that the association observed is 
not attributable to differences by subgroups in 
preoperative cognitive function.
The form of the linear model is:
Cognitionij=β×[1+Ageij+Ageij
2+ 
(EverSurgeryi+EverMedicali+EverStrokei)
2+ 
CognitiveAssessmentsi+ 
(Surgeryij+Medicalij+Strokeij)
2+ 
Covariatesi+Covariatesi×Ageij+ 
CovariatesTDij]+γi×[1+Ageij]+εij
Grouped squared terms indicate two way 
interactions. Subscript i indicates predictors that vary 
across participants and subscript j indicates predictors 
that vary across cognitive assessments within one 
participant. “Ever” surgical admissions, medical 
events, and strokes represent occurrence of at least 
one of that event any time during the study period; 
therefore, these represent constant adjustments 
to the participant’s baseline. Covariatesi indicates 
adjustment for covariates that were measured at 
baseline, and CovariatesTDij indicates time dependant 
covariates. Models were also adjusted for the total 
number of cognitive assessments to correct for 
increased dropout of participants who started with 
lower cognitive scores, and include random effects for 
participant and a random slope with age, presuming 
that participants start at different baselines and vary 
in rate of cognitive decline. The primary coefficients 
of interest are those representing the number of 
surgery, medical, and stroke admissions before a given 
cognitive assessment. Those coefficients represent 
a cognitive step change occurring at the time of 
admission and persisting.
Overall, our approach presumes that participants 
differ in both their baseline cognitive abilities and 
comorbidities and their rate of decline with age. In 
the analysis we attempt to identify any additional 
cumulative change after surgery and hospital 
admission. We compared this approach to an 
alternative that treats hospital admissions as overall 
markers of ill health, resulting in differences in the 
overall cognitive trajectory without any particular 
impact at the time of the admission. In this model, 
the only variable that changes with time for a given 
subject is age:
Cognitionij=β×[1+Ageij+Ageij
2+Ageij× 
(TotalSurgeryi+TotalMedicali+TotalStrokei)
2+ 
CognitiveAssessmentsi+Covariatesi+Covariatesi× 
Ageij+CovariatesTDij] +γi×[1+Ageij]+εij
Because this model was inferior based on the 
deviance information criterion, our analyses focused 
on the step change model.
All models were fit using the R package MCMCglmm30 
and custom code written in R. For final model fits 
we used 3000 burn-in trials followed by 100 000 
iterations thinned to every 10 trials. Autocorrelation 
plots and Gelman-Rubin diagnostic31 32 were used 
to confirm model convergence with the help of the R 
package coda.33
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Sensitivity analyses
In parallel to the models fit to the entire study sample, 
we analyzed a subset of 4916 participants with at least 
four cognitive assessments. In this population, we 
can better follow the cognitive trajectory in individual 
participants and our estimates could be less susceptible 
to confounding factors that cause participants to drop 
out of the study. In further models, we tested the impact 
of surgery not requiring a hospital stay of two nights, 
focusing on only BUPA major operations, excluding 
participants in high risk surgical categories (cardiac, 
thoracic, vascular, and intracranial neurosurgery), 
emergency surgery, participants with surgery before 
age 65, and those who had surgery after the beginning 
of the study period but before they completed their first 
cognitive assessment, and incorporating covariates.
Interpretation of model parameter estimates
We report posterior means and bayesian 95% credible 
intervals. Credible intervals indicate the range of 
parameter estimates that are likely given the data. We 
chose a bayesian approach because we believe that an 
effect or no effect judgment based on a null hypothesis 
test is not the most useful or informative statistic in 
the context we study, and related P values are often 
misinterpreted.34 Rather, the statistic that is most 
relevant and most easily interpreted by clinicians and 
patients is the range of expected average outcomes.35 
For example, a small but statistically significant 
clinical risk could be irrelevant to patients’ decisions, 
whereas a large but statistically inconclusive clinical 
risk is important. Interpreting model coefficients in 
terms of a range of plausible outcomes, especially 
estimates of the upper bound to risk, is most important 
to patients and clinicians.
Missing data
To account for occasional missing demographic 
data, we generated 100 imputed datasets using the R 
package MICE,36 fit Markov chain Monte Carlo models 
to each, and computed credible intervals for each fixed 
effect across the imputed models.37
Identifying substantial decline
As an alternative approach, we tested for the most 
severe (rather than average) cognitive decline 
outcomes. We predicted the composite cognitive scores 
for the final cognitive assessment (either the fourth 
or the fifth study wave) based on extrapolation from 
the first three assessments in each participant. Those 
with medical or surgical admissions before the third 
cognitive assessment, as well as those with stroke at 
any point during the study, were excluded, leaving 
3633 participants for this approach. We fit a linear 
mixed effects model with age and age squared as 
fixed effects, and participant as a random effect with 
random slopes for age. Using this model, we predicted 
the cognitive score for each participant at their final 
cognitive assessment for the study, including their 
random intercept and slope. We subtracted these 
predicted cognitive scores from the actual cognitive 
scores at that final assessment, and then z scored 
these residuals across participants. In accordance with 
prior studies, we defined participants with z scored 
residuals of less than −1.96 as those experiencing 
“substantial decline” relative to prediction.10 38 39 We 
then fit a logistic regression for substantial decline as 
a function of having at least one surgery, at least one 
medical admission, or both before the final cognitive 
assessment, and adjusted for age at the final cognitive 
assessment.
Patient and public involvement
At its initiation, participants recruited to the Whitehall 
II study were not involved in setting the research 
agenda, recruitment strategies, or study design. We did 
not invite participants to advise on interpretation or 
dissemination of our results. Nonetheless, participants 
receive study results through the Whitehall II website 
and newsletters. In 2015 the Whitehall II study 
randomly selected some participants to take part in a 
consultation exercise to guide the research agenda.
Results
Figure 1 shows sample selection. Seven participants 
were excluded owing to errors in the hospital episode 
statistics database, leaving 7532 people with at least 
one cognitive assessment. Overall, 8982 entries were 
deemed “major” events and comprised 4525 operations 
(table 1), 4306 medical admissions, and 151 strokes. A 
total of 5110 entries in hospital episode statistics were 
made after the first cognitive assessment and before 
the last cognitive assessment in the study (number 
of admissions: 2932 operations, 2114 medical, and 
64 strokes). Table 2 summarizes demographic and 
admission data for participants. Figure 2 summarizes 
the age at event and extent of follow-up after surgical 
and medical admissions.
We checked our a priori expectation that acute 
events incur a contemporaneous cognitive impact 
(step change model) by comparing with an alternative 
model in which admissions were treated as markers of 
chronic ill health that impact cognition continuously 
(rather than at the time of admission). This alternative 
model was inferior (change in deviance information 
criteria=113), so we considered only the step change 
model.
In the model of cumulative burden of surgical, 
medical, and stroke admissions (excluding covariates 
except the number of cognitive assessments), we found 
that surgical admissions were associated with only a 
small long term change in cognition (−0.014 units (95% 
credible interval −0.029 to 0.000), equivalent to 0.01 
to 0.73 years of cognitive aging; table 3). Major medical 
admissions were associated with a significantly larger 
decrease in cognitive function than surgical admissions 
(−0.056 units (−0.073 to −0.040), equivalent to 1.0 
to 1.8 years of cognitive aging, P<0.001 for contrast 
between surgery and medical admissions). Stroke was 
associated with a severe cognitive decrease (−0.52 
units (−0.65 to −0.38), equivalent to 9.6 to 16 years of 
cognitive aging, table 3). Results with a smaller subset 
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of participants who completed at least four cognitive 
assessments (n=4916) were similar (table 3).
To contextualize the magnitude of the changes 
described, we also computed the change in individual 
cognitive tests. The post-surgical effect averaged a 
decrease of 0.02 recalled memory items, 0.15 fewer 
points on the executive function test, and 0.17 fewer 
words in the combined verbal and semantic fluency 
test (table 3). The magnitude of these average score 
changes are small: less than 1 point on any of the tests.
These results so far indicate the effect of surgery 
alone or medical admission alone. Interactions 
between types of admissions (surgical, medical, and 
stroke) were in the direction of cognitive improvement 
rather than a steeper decline (indicating that cognition 
for someone having both a surgery and a separate 
medical admission declined less than the summed 
expected decline from each separate event). Consistent 
with this assumption, if these interactions were not 
included, the estimates of cognitive decline associated 
with surgical (−0.010 units (−0.023 to 0.003)) or 
medical events (−0.048 units (−0.063 to −0.035)) 
would be revised downwards.
To summarize our model results, we plotted predicted 
cognitive trajectories for hypothetical participants 
(fig 3). In these predicted trajectories the overall 
trajectory with age was the dominant feature (change 
in cognitive score between ages 60 and 75 years=0.83 
units, where 1 unit represents the standard deviation 
of the population scores at the first assessment), and 
a major surgical hospital admission had little impact 
relative to the age related trajectory. In contrast, stroke 
was associated with a clear effect on cognition. Our 
model allowed a lower baseline cognitive score in 
participants who would go on to have surgery, medical 
admissions, or stroke compared with those who did 
not (fig 3). These participants had a lower cognitive 
score at entry to the study, different from those who 
did not have surgery (−0.13 units (−0.18 to −0.078), 
equivalent to being 2.0 to 4.5 years cognitively older). 
Participants who had medical admissions (−0.12 
units (−0.18 to −0.060), equivalent to 1.5 to 4.5 years 
cognitively older) also had lower baseline cognitive 
Table 1 | Classification of major surgical operations in study and those occurring before the last cognitive assessment in each participant. Values are 
numbers (percentages)
Major surgery Whole study* (n=4525 admissions) Cognitive follow-up (n=2932 admissions)
Cardiac:
 Overall 219 (4.8) 153 (5.2)
 Valve 61 (1.3) 37 (1.3)
 Other 158 (3.5) 116 (4.0)
Thoracic: overall 182 (4.0) 85 (2.9)
Vascular:
 Overall 139 (3.1) 84 (2.9)
 Intervention 48 (1.1) 28 (1.0)
 Other 91 (2.0) 56 (1.9)
Intracranial neurosurgery: overall 89 (2.0) 38 (1.3)
Major non-intracranial/non-cardiothoracic/non-vascular:
 Overall 3896 (86.1) 2572 (87.7)
 General 1267 (28.0) 766 (26.1)
 Orthopedic 1325 (29.3) 971 (33.1)
 Other 1304 (28.8) 835 (28.5)
*Includes all surgical operations that occurred between baseline (1997-99) and March 2017, including those after the latest available cognitive assessment.
At least four cognitive assessments, no major events before third assessment
Primary analysis: cumulative impact*
Whitehall II cohort study
Errors in hospital episode statistics
10 308
Whitehall II + hospital episode statistics cohort
10 301
Cognitive cohort
7
No cognitive assessments
2769
7532
No major admissions
4954
Medical Both Surgical
715 613 1250
Secondary analysis: substantial decline†
No major admissions
3054
Medical Both Surgical
141 77 361
Fig 1 | Inclusion of participants from Whitehall II cohort study and hospital episode 
statistics. Numbers in parentheses refer to participants, not events. *Medical 
admissions include stroke. Admissions after the final cognitive assessment are not 
included as cognitive impact cannot be assessed. †Participants with stroke excluded 
from this analysis
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score, and stroke trended in that direction (−0.11 
units (−0.36 to 0.12), equivalent to −3.1 to 9.0 years 
cognitively older), though the credible interval was 
wide because strokes were rare.
Alternate modeling approach
We confirmed that similar results would be obtained 
with an alternate approach to model estimation using 
the same model structure and data, such as penalized 
least squares through the R package lme4.40 This 
approach gave nearly identical estimates of cognitive 
decline as that obtained from the MCMC approach 
(surgery −0.014 (95% credible interval −0.028 to 
0.001); medical −0.055 (−0.073 to −0.039); stroke 
−0.52 (−0.65 to −0.38)).
Sensitivity analyses
Because surgical admissions included some categories 
that have been specficially associated with cognitive 
decline,11 we performed sensitivity analyses excluding 
participants from categories of high risk surgical 
admissions and participants undergoing emergency 
surgery (table 4). Excluding participants in any 
one of these categories did not substantially affect 
the relation between surgery and cognitive scores, 
although excluding emergency surgery had the largest 
impact. Some surgical admissions that we counted as 
“major” according to duration of hospital stay were 
nonetheless associated with procedure codes that 
were not classified as major surgery according to BUPA 
scoring. However, focusing only on major operations 
according to BUPA (and requiring at least a two night 
stay), did not alter the estimate of the surgical impact 
(table 4).
We tested for a biological gradient for the surgical 
effect by adding cumulative minor surgical admissions 
as a separate factor in the model. Minor surgery (not 
requiring a two night stay) was not associated with 
change in cognition (0.13 years of cognitive aging 
(−0.06 to 0.32)); major surgery remained associated 
with a small change in cognition (0.59 years of cognitive 
aging (0.14 to 1.0)). Finally, we included covariates 
from table 2 in the analysis, assessed at baseline, and 
their interactions with age, using multiple imputation 
for missing demographic data. Results remained 
substantially the same (surgical event: 0.34 years of 
cognitive aging (0.00 to 0.68) or medical events: 1.2 
years of cognitive aging (0.83 to 1.6)).
A sensitivity analysis based on the age of exposure 
to surgery was conducted based on the hypothesis 
that older participants would be more vulnerable 
to the cognitive effects of surgery. Next, we excluded 
participants with surgical admissions before age 
65. Contrary to the hypothesis, these data showed a 
reduced impact associated with surgery at older ages 
(table 4).
Table 2 | Participant characteristics and events by participant category*
Baseline characteristics Overall (n=7532)
Hospital admissions
P value†None (n=4954) Any surgery (n=1863) Medical only (n=715)
Mean (SD) age (years) 55.5 (5.99) 55.0 (5.95) 56.6 (5.88) 56.4 (6.1) <0.001
Women 2235 (29.7) 1465 (29.6) 599 (32.2) 171 (23.9) <0.001
Race:
 White 6874 (91.5) 4553 (92.0) 1694 (91.1) 627 (87.9) 0.001 Non-white 645 (8.6) 394 (8.0) 165 (8.9) 86 (12.0)
 Missing 13 7 4 2
Education level (years):
 0-12 1958 (29.1) 1297 (29.2) 501 (30.1) 160 (25.6)
0.09 13-17 3000 (44.6) 2000 (45.0) 704 (42.3) 296 (47.4)
 ≥18 1771 (26.3) 1145 (25.8) 458 (27.5) 168 (26.9)
 Missing 803 512 200 91
Maximum employment position:
 High 3413 (45.3) 2305 (46.5) 784 (42.1) 324 (45.3)
0.02 Intermediate 3219 (42.7) 2077 (41.9) 835 (44.8) 307 (42.9)
 Low 900 (12.0) 572 (11.6) 244 (13.1) 84 (11.8)
Mean (SD) Framingham CVD risk score‡ 0.20 (0.12) (n=6792) 0.19 (0.11) (n=4578) 0.21 (0.12) (n=1600) 0.22 (0.12) (n=614) <0.001
Diabetes 889 (11.8) 495 (10.0) 277 (14.9) 117 (16.3) <0.001
Smoking:
 Current 684 (10.0) 438 (9.7) 180 (10.7) 66 (10.4) 0.21 Former 2774 (40.7) 1803 (40.1) 716 (42.5) 255 (40.3)
 Never 3353 (49.2) 2255 (50.1) 787 (46.8) 311 (49.1)
 Missing 721 459 180 82
Medical and surgical events:
 Mean (SD) surgical admissions 0.39 (0.85) 1.6 (1.0)
 Stroke 63 (0.8) 28 (1.5) 35 (4.9)
 Any medical admission 1328 (18) 613 (33) 715 (100)
  Mean (SD) medical admissions 0.29 (0.84) 0.60 (1.2) 1.5 (1.2)
Mean (SD) follow-up:
 No of assessments 3.8 (1.4) 3.6 (1.5) 4.1 (1.1) 3.9 (1.2) <0.001
 Duration (years) 14.6 (5.56) 13.8 (6.25) 16.3 (3.25) 15.7 (3.85) <0.001
*Categories are based on events occurring before each participant’s last cognitive assessment. Missing values are excluded from percentages.
†P values are from I2 tests (categorical) or one way analysis of variance F tests (continuous) comparing across never surgery or never medical, any surgery, and medical only categories.
‡Averages and standard deviations are based on subset of participants owing to missing values.
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Incidence of substantial decline
The small average effects we report could reflect 
large changes in a few participants rather than 
small, hardly noticeable changes in each participant. 
Therefore, although critiqued,15 some prior studies of 
postoperative cognitive decline have focused on the 
number of participants with the greatest declines,10 38 39 
presuming that participants who show substantial 
Age at event (years)
Surgical admissions
N
o 
of
 e
ve
n
ts
0
100
150
200
50
40 50 60 70 80 90
Time post-admission (years)
C
u
m
u
la
ti
ve
 c
og
n
it
iv
e
as
se
ss
m
en
ts
 a

er
 a
dm
is
si
on
0
400
600
800
200
0 10 15 205
Age at event (years)
Medical admissions
40 50 60 70 80 90
Time post-admission (years)
0 10 15 205
Fig 2 | Age and duration of follow-up for surgical operations and medical admissions. (Top panel) Participant age at time of event. (Bottom panel) 
Cumulative follow-up duration of cognitive assessments after major events. Counts reflect both number of admissions and number of cognitive 
assessments and therefore each assessment is counted once for each preceding event and there are multiple assessments per participant
Table 3 | Cognitive impact of surgical admissions, medical admissions, and stroke
Admission category Composite score Memory Executive function Verbal fluency
≥1 cognitive assessment (n=7532 participants)
Cognitive impact (95% CI)*
Admissions:
 Surgical −0.014 (−0.029 to −0.000) −0.017 (−0.071 to 0.035) −0.15 (−0.30 to −0.007) −0.15 (−0.29 to −0.025)
 Medical −0.056 (−0.073 to −0.040) −0.066 (−0.13 to −0.007) −0.57 (−0.74 to −0.41) −0.42 (−0.57 to −0.27)
 Stroke −0.52 (−0.65 to −0.38) −1.0 (−1.5 to −0.52) −5.2 (−6.5 to −3.8) −3.5 (−4.7 to −2.3)
Years equivalent cognitive impact (95% CI)†
Admissions:
 Surgical 0.35 (0.01 to 0.73) 0.18 (−0.35 to 0.71) 0.55 (0.03 to 1.1) 0.63 (0.10 to 1.2)
 Medical 1.4 (1.0 to 1.8) 0.67 (0.07 to 1.3) 2.1 (1.5 to 2.7) 1.7 (1.1 to 2.3)
 Stroke 13 (9.6 to 16) 10 (5.2 to 16) 19 (14 to 24) 14 (9.3 to 19)
≥4 cognitive assessments (n=4916 participants)
Cognitive impact (95% CI)*
Admissions:
 Surgical −0.017 (−0.034 to −0.000) −0.020 (−0.077 to 0.037) −0.15 (−0.30 to 0.003) −0.17 (−0.31 to −0.028)
 Medical −0.073 (−0.096 to −0.051) −0.11 (−0.19 to −0.035) −0.57 (−0.78 to −0.36) −0.53 (−0.72 to −0.33)
 Stroke −0.65 (−0.80 to −0.49) −1.3 (−1.9 to −0.69) −5.2 (−6.7 to −3.8) −3.9 (−5.3 to −2.5)
Years equivalent cognitive impact (95% CI)†
Admissions:
 Surgical 0.41 (0.01 to 0.81) 0.20 (−0.38 to 0.78) 0.59 (−0.01 to 1.2) 0.71 (0.12 to 1.3)
 Medical 1.7 (1.2 to 2.3) 1.1 (0.35 to 1.9) 2.3 (1.4 to 3.1) 2.3 (1.4 to 3.1)
 Stroke 15 (12 to 19) 13 (7.0 to 19) 21 (15 to 26) 17 (11 to 22)
*Cognitive impact for composite scores are in z scored composite units per event, estimated from models adjusted for baseline effects of admissions and number of cognitive assessments, as 
well as random intercepts for participant and slope with age. Negative numbers indicate decline. For individual tests, units are in the scoring units on that test: questions correct (memory and 
executive function) or total number of words (verbal fluency).
†Years equivalent is calculated by dividing by the linear term for age in each model. Because changes with time are negative, negative numbers indicate improvement. Because tests in each 
domain are not on the same numeric scale, comparisons between cognitive domains should utilize the normalized “years equivalent” measure.
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decline are more likely to experience consequences 
that affect quality of life. Using participants who had 
no medical or surgical admissions early in the study 
(before the third cognitive assessment) and no stroke 
(total n=3633 participants), we extrapolated estimated 
cognitive scores at the final cognitive assessment and 
identified participants with substantial decline relative 
to prediction; out of the 3633 participants,115 (3.2%) 
people showed substantial decline (20/361 surgery, 
18/141 medical, 4/77 surgery and medical, 77/3054 
neither).
Compared with participants who had no major 
hospital admissions, those with surgical or medical 
events were more likely to have substantial decline 
(surgical admissions odds ratio 2.3 (95% credible 
interval 1.4 to 3.9); medical admissions odds ratio 
6.2 (3.4 to 11.0); both surgery and medical odds ratio 
2.0 (0.64 to 6.0)). Participants who had only medical 
events were more likely to show substantial decline 
than participants who only had surgical events (95% 
credible interval for posterior density difference 1.4 to 
6.1, P=0.004). Adding terms for the age at (earliest) 
surgery did not have a significant effect (P=0.47) if age 
at final assessment was included as a covariate.
Discussion
This longitudinal study of 7532 people identified a 
small decrease in cognitive performance associated 
with surgery, equivalent to less than five months of 
mean cognitive decline. Hence we estimate a cognitive 
age of 67 years and 10 months for a participant who 
incurred surgery at the median age of 67 years and 5 
months. To further contextualise this finding, the mean 
effect of a surgery is less than one standard deviation 
of the normal annualized decline in the population. 
Declines of less than one standard deviation of the 
age related cognitive trajectory have been suggested to 
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lack clinical significance.20 We also found no evidence 
from the different sets of analyses, including variations 
in the participant population and adjustment for 
confounding, that on average this decrease could be 
greater than 12 months equivalent of cognitive aging. 
Major surgery was associated with less cognitive 
impact than major medical events or stroke although 
the effect was greater than for minor surgery. Indeed on 
average stroke was associated with a 37-fold larger and 
medical admissions four-fold larger cognitive effect 
than major surgery.
Systematic reviews of studies that largely did not 
consider the cognitive trajectory have suggested that 
any cognitive effect of surgery is detectable for six 
months at maximum.9 41 Our results, however, suggest 
that on average major surgery might be associated with 
a long term change in cognition, but the mean effect 
is small—equivalent to less than a year of aging. Our 
data do suggest an increase in the odds of substantial 
cognitive decline after surgery, affecting 5.5% of people 
compared with 2.5% without major admissions. 
Hence while at the population level the mean effect 
is small, the risk of a large cognitive “hit” is about 
doubled, though this affects only a small percentage 
of the population. The threshold for our definition of 
substantial cognitive decline—a deviation of more 
than 1.96 standard deviations—has been proposed to 
be clinically important.10 20
Comparison with previous studies
A previous study did not find an effect of surgery 
(n=180) or major medical illness (n=119) on the 
cognitive trajectory when data were analyzed from 
the Alzheimer’s Disease Research Center (n=575).12 
More recently, a study using four waves of data 
(n=431) found that incident surgery during eight 
years of cognitive follow-up was not associated 
with decline.42 In a larger cohort, the same authors 
suggested that surgery in the prior 20 years was 
associated with cognitive decline over the subsequent 
eight years42; however, this design cannot exclude 
that this effect could be attributable to lower cognitive 
performance before surgery contrary to the present 
analyses that account for these differences. Another 
study, of 130 participants who had surgery between 
cognitive assesssments (similar to our methods) in the 
Wisconsin Registry for Alzheimer’s Protection study 
(completed over nine years), found that a cumulative 
number of operations was associated with a decline 
in short term memory but not in executive function.43 
This study did not, however, analyse other types 
of admissions, such as medical. A similar problem 
affected another study,44 which showed no difference 
in cognitive decline between patients undergoing self 
reported cardiac surgery or cardiac catheterization. 
Nonetheless, it is interesting that their estimate of 
4.6 months of cognitive aging associated with cardiac 
surgery is closely aligned to our estimate. Multiple 
studies have provided estimates of a binary incidence 
of cognitive decline, though these have been hard to 
synthesize owing to varying definitions of decline,8 
and largely these studies were unable to account 
for the preoperative trajectory. Systematic reviews 
have failed to find convincing evidence for long term 
effects on cognition using these binary endpoints.8 9 41 
Our data are consistent with a low incidence of long 
term substantial cognitive decline. We were likely 
able to detect this low incidence based on both the 
large sample size and the design utilizing a predicted 
preoperative cognitive trajectory.
Strengths and limitations of this study
The results from our study are robust for several reasons. 
First, our sample size is larger and we had longer 
follow-up than in previous studies, providing greater 
power to estimate the association between surgery 
and the cognitive trajectory. Second, we examined 
admissions for medical conditions separately from 
surgical admissions as considering them together 
could exaggerate any association with surgery. This is 
important given that our results show medical events 
to have a more profound association with the cognitive 
trajectory. Third, our modeling approaches allow for a 
better assessment of the age related cognitive trajectory 
than previous approaches12 42 43—for example, fitting 
an age2 term to allow for accelerated cognitive decline 
with aging.28 Our analyses also suggest that modeling 
a step change around the time of the event better 
fits the data than the longitudinal changes in the 
trajectory used in previous studies.12  34  35 Fourth, all 
events occurred over the same period as the cognitive 
assessments, therefore we were able to estimate 
cognition both before and after surgery. Some studies 
relied on operations occurring before the period of 
cognitive assessments, potentially over-estimating 
the association between surgery and the trajectory. 
Our statistical models allowed variations in individual 
trajectories and differences in cognitive performance 
before admissions. Fifth, we also examined cognitive 
decline in medical admissions and in participants 
after stroke, as well as in minor surgery, to allow 
inferences about the effect size of surgery and testing 
for a biological gradient of the effect of surgery. Sixth, 
we also investigated the association between major 
surgical and medical admissions and the incidence 
of substantial cognitive decline, as defined by more 
than 1.96 standard deviations from predicted. This 
result showed that surgery was associated with a 
doubling in the odds of substantial decline, which was 
smaller than for major medical admission. Seventh, 
postoperative cognitive improvement has been noted 
after surgery,15 and our analytic approach allowed for 
detection of both improvement or decline. However we 
found little evidence to support postoperative cognitive 
improvement in our results.
One surprising result from the sensitivity analyses 
was that in people who did not have surgery before 
age 65, subsequent surgical admissions were not 
associated with any cognitive decline. This result might 
reflect a selection bias in type of surgery conducted at 
different ages, or that longer hospital stays in younger 
patients are associated with surgical complications, 
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or other factors contribute to a measurable impact. 
Alternatively, it could support the hypothesis that 
surgery at younger ages is a marker of poorer health 
or more aggressive disease that are associated with 
subsequent cognitive decline. Our study lacks data 
to resolve these alternatives—however, we emphasize 
that the mean estimates in both age groups were 
smaller than those seen to be clinically significant in 
prior studies.10 20
Our study has several limitations. As with all 
observational studies we cannot ascribe causality to 
our findings. Indeed hospital admissions likely act as a 
surrogate measure for ill health, and separating the role 
of surgery from the underlying health condition is not 
possible with these data. The hospital episode statistics 
database also lacks data on the type of anesthesia 
administered, limiting our ability to assess the role 
of anesthesia in any long term cognitive change. As 
surgical admissions could serve as a surrogate measure 
for health, it might be most appropriate to interpret 
our estimated associations as an upper bound on the 
cognitive impact of surgery itself, with the remainder 
of the association ascribed to health condition 
necessitating surgery. The use of administrative 
health data to detect admissions could be considered 
suboptimal; however, audits show an approximate 
96% accuracy for detecting events recorded in hospital 
episode statistics,21 which is likely more reliable 
than self report of events.44 Objective classification of 
cognitive decline might also over-estimate subjective 
cognitive problems,45 providing another reason why 
our results should be considered the upper bound for 
the impact of surgery on cognition. Finally, with any 
longitudinal study, we can expect loss to follow-up and 
this might have affected participants with the greatest 
impairment. With only 63 participants with stroke, 
we were able to show cognitive decline despite loss 
to follow-up. Hence loss to follow-up likely affected 
stroke and medical events to a greater extent than 
surgical events. We acknowledge that catastrophic 
events, such as stroke or covert stroke, can occur in the 
perioperative period and have cognitive consequences. 
These infrequent but known risks might underlie the 
observed increase in substantial cognitive decline. 
We did not seek to underestimate the impact of these 
surgery related events on the cognitive trajectory; 
however, we have labeled a stroke occurring within 
two weeks of surgery in this study as a surgical event 
and hence this would have contributed to any decline 
associated with surgery. These events are already 
established complications of surgery and are discussed 
during informed consent. Finally, we emphasize that 
our findings might not be generalizable to other 
groups, including those with more ethnic diversity and 
those with greater numbers of participants older than 
70 years old, when the incidence of clinical diagnoses 
of cognitive decline, such as dementia, increases.
Conclusions
Overall our data suggest that major surgery is 
associated with a small long term mean change in 
the age related cognitive trajectory, with the odds of 
substantial decline doubling. Hence although the 
mean association is small and the absolute incidence 
of substantial cognitive decline is low, major surgery 
is associated with a long term effect on cognition. 
This information should be conveyed to patients and 
be weighed against the potential health and quality 
of life benefits of surgery during informed consent 
discussions with patients.
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